Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Time to first cigarette and serum cholesterol levels.

Selya AS, Hesse ND.

Soc Sci Med. 2017 Feb;174:213-219. doi: 10.1016/j.socscimed.2016.12.014. Epub 2016 Dec 30.

PMID:
28041641
2.

Can Stopping Nerves, Stop Cancer?

Saloman JL, Albers KM, Rhim AD, Davis BM.

Trends Neurosci. 2016 Dec;39(12):880-889. doi: 10.1016/j.tins.2016.10.002. Epub 2016 Nov 8. Review.

3.

Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating α5-nAChR/AKT Signaling in Human Gastric Cancer Cells.

Jia Y, Sun H, Wu H, Zhang H, Zhang X, Xiao D, Ma X, Wang Y.

PLoS One. 2016 Feb 24;11(2):e0149120. doi: 10.1371/journal.pone.0149120. eCollection 2016.

4.

Apoptosis Activation in Human Lung Cancer Cell Lines by a Novel Synthetic Peptide Derived from Conus californicus Venom.

Oroz-Parra I, Navarro M, Cervantes-Luevano KE, Álvarez-Delgado C, Salvesen G, Sanchez-Campos LN, Licea-Navarro AF.

Toxins (Basel). 2016 Feb 5;8(2):38. doi: 10.3390/toxins8020038.

5.

Determination of Nicotine in Tobacco by Chemometric Optimization and Cation-Selective Exhaustive Injection in Combination with Sweeping-Micellar Electrokinetic Chromatography.

Lin YH, Feng CH, Wang SW, Ko PY, Lee MH, Chen YL.

J Anal Methods Chem. 2015;2015:869719. doi: 10.1155/2015/869719. Epub 2015 May 26.

6.

Noribogaine reduces nicotine self-administration in rats.

Chang Q, Hanania T, Mash DC, Maillet EL.

J Psychopharmacol. 2015 Jun;29(6):704-11. doi: 10.1177/0269881115584461. Epub 2015 May 20.

7.

Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility.

Wang JQ, Qi RR, Zhou W, Tang YF, Pan LL, Cai YL.

PLoS One. 2015 Apr 24;10(4):e0124203. doi: 10.1371/journal.pone.0124203. eCollection 2015.

8.

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Ameli N, Schatzberg AF, Murphy GM Jr.

Nicotine Tob Res. 2015 Sep;17(9):1126-33. doi: 10.1093/ntr/ntu273. Epub 2015 Jan 8.

9.

Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.

Kompella SN, Hung A, Clark RJ, Marí F, Adams DJ.

J Biol Chem. 2015 Jan 9;290(2):1039-48. doi: 10.1074/jbc.M114.605592. Epub 2014 Nov 19.

10.

Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.

Perumal D, Pillai S, Nguyen J, Schaal C, Coppola D, Chellappan SP.

Oncotarget. 2014 Nov 15;5(21):10486-502.

11.

Conotoxins targeting nicotinic acetylcholine receptors: an overview.

Lebbe EK, Peigneur S, Wijesekara I, Tytgat J.

Mar Drugs. 2014 May 22;12(5):2970-3004. doi: 10.3390/md12052970. Review.

12.

NeuroD1 mediates nicotine-induced migration and invasion via regulation of the nicotinic acetylcholine receptor subunits in a subset of neural and neuroendocrine carcinomas.

Osborne JK, Guerra ML, Gonzales JX, McMillan EA, Minna JD, Cobb MH.

Mol Biol Cell. 2014 Jun;25(11):1782-92. doi: 10.1091/mbc.E13-06-0316. Epub 2014 Apr 9.

13.

Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D.

Carcinogenesis. 2014 May;35(5):1039-45. doi: 10.1093/carcin/bgu010. Epub 2014 Jan 13.

14.

Medial habenula output circuit mediated by α5 nicotinic receptor-expressing GABAergic neurons in the interpeduncular nucleus.

Hsu YW, Tempest L, Quina LA, Wei AD, Zeng H, Turner EE.

J Neurosci. 2013 Nov 13;33(46):18022-35. doi: 10.1523/JNEUROSCI.2927-13.2013.

15.

Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.

Grishin AA, Cuny H, Hung A, Clark RJ, Brust A, Akondi K, Alewood PF, Craik DJ, Adams DJ.

J Biol Chem. 2013 Nov 29;288(48):34428-42. doi: 10.1074/jbc.M113.512582. Epub 2013 Oct 7.

16.

Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors.

Flora AV, Zambrano CA, Gallego X, Miyamoto JH, Johnson KA, Cowan KA, Stitzel JA, Ehringer MA.

Brain Res. 2013 Sep 5;1529:1-15. doi: 10.1016/j.brainres.2013.07.017. Epub 2013 Jul 18.

17.

Association between a 15q25 gene variant, nicotine-related habits, lung cancer and COPD among 56,307 individuals from the HUNT study in Norway.

Gabrielsen ME, Romundstad P, Langhammer A, Krokan HE, Skorpen F.

Eur J Hum Genet. 2013 Nov;21(11):1293-9. doi: 10.1038/ejhg.2013.26. Epub 2013 Feb 27.

18.

Defining the putative inhibitory site for a selective negative allosteric modulator of human α4β2 neuronal nicotinic receptors.

Henderson BJ, González-Cestari TF, Yi B, Pavlovicz RE, Boyd RT, Li C, Bergmeier SC, McKay DB.

ACS Chem Neurosci. 2012 Sep 19;3(9):682-92. Epub 2012 May 25.

19.

Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.

Henderson BJ, Carper DJ, González-Cestari TF, Yi B, Mahasenan K, Pavlovicz RE, Dalefield ML, Coleman RS, Li C, McKay DB.

J Med Chem. 2011 Dec 22;54(24):8681-92. doi: 10.1021/jm201294r. Epub 2011 Nov 18.

20.

Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.

Murphy SE, von Weymarn LB, Schutten MM, Kassie F, Modiano JF.

Cancer Prev Res (Phila). 2011 Nov;4(11):1752-60. doi: 10.1158/1940-6207.CAPR-11-0366. Epub 2011 Oct 25.

Supplemental Content

Support Center